While illuminating, even these statistics fall short of showing the less measurable, far-reaching consequences of head traumas in patients’ everyday lives. Across the globe, there are 4.7 million TBI-related deaths each year, with 90% estimated to occur in low- and middle-income countries.In Europe, an estimated 6.3 million people live with a TBI-related disability.In the United States, there are 1.5 million cases of TBI each year and an estimated 5.3 million people living with a TBI-related disability.In the United Kingdom, about 1.3 million people live with a disability caused by a head injury.Here are a few statistics revealing the toll of traumatic brain and head injuries around the world: In fact, TBIs are often referred to as “the silent epidemic” because the symptoms of brain injuries aren’t always apparent after an incident occurs. The costs of traumatic brain injuries (TBIs) - one of the leading causes of death and disability worldwide, with an estimated 69 million people newly affected each year - are enormous and often go unnoticed. Together, they will apply artificial intelligence (AI) models to digital cognitive assessments used primarily for identifying Alzheimer’s Disease and dementia. Mila – Quebec AI institute, the world’s largest academic deep learning (DL) research center has established a partnership with MoCA Cognition, the company behind the world’s leading test for early detection of cognitive impairment. Mila is a non-profit organization recognized worldwide for its significant contributions to the field of deep learning, particularly in language modeling, machine translation, object recognition, and generative models. Based in Montreal, Mila’s mission is to be a global hub for scientific advances that inspire innovation and development of AI for the benefit of all. 2023)įounded by Professor Yoshua Bengio of the University of Montreal, Mila is an artificial intelligence research institute that brings together over 1,000 researchers specializing in machine learning. MoCA was ranked number 1 among 53 cognitive screening tests (Outcome Measures for Alzheimer’s Disease: A global inter-societal Delphi consensus. Our mission is fueled by our passionate belief that everyone deserves a memorable life. Early diagnosis and treatment plans improve brain health and well-being. Nasreddine leads MoCA Cognition, a research and innovation-focused company driven to deliver the next generation of cognitive screening solutions. Along with his continued dedication to patients at his memory clinic and center for clinical trials that welcomes over 2,000 patients per year, Dr. Ziad Nasreddine created a specialized test that could directly support hospitals and specialty clinics with high volume of patients: the Montreal Cognitive Assessment-or MoCA. This partnership aims to optimize the current suite of digital tools offered by MoCA Cognition, and potentially develop new approaches that will benefit clinicians, researchers, patients, and families world-wide.ĭr. This is precisely the kind of project and team we aim to partner with to deliver novel solutions that can have a real impact,” shared Stéphane Létourneau, Mila’s Executive Vice-President. “We are encouraged by MoCA Cognition’s dedication to AI-enhanced cognitive screening tools, applicable in health care worldwide. Together we are tackling brain diseases that affect at least one person each of us knows.” said MoCA Cognition CEO, Dr. “Working with Mila feels like a natural fit as we are both proudly Montreal-based entities with a shared motivation to apply AI and DL strategies to big global issues. Nasreddine now leads MoCA Cognition, developing the next generation of screening tools, designed for tablets, smartphones, and browsers. The MoCA Test has since become the preferred screening test, used in over 200 languages and dialects. Ziad Nasreddine created the Montreal Cognitive Assessment, or MoCA Test, as a pen and paper test helping clinicians and researchers rapidly scan multiple cognitive domains and detect impairment. The annual global cost of dementia is expected to rise to 2.8 trillion USD by 2030. Together, they will apply artificial intelligence (AI) models to digital cognitive assessments used primarily for identifying Alzheimer’s Disease and dementia.Alzheimer’s Disease International projects over 100 million people will be living with dementia in the next 10 years.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |